RT Journal Article
SR Electronic
T1 High Mortality Associated with Chikungunya Epidemic in Southeast Brazil, 2023
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.03.24309912
DO 10.1101/2024.07.03.24309912
A1 Freitas, Andre Ricardo Ribas
A1 Lima Neto, Antonio Silva
A1 Oliveira, Erneson Alves
A1 Andrade, José Soares
A1 Cavalcanti, Luciano Pamplona
YR 2024
UL http://medrxiv.org/content/early/2024/07/05/2024.07.03.24309912.abstract
AB The chikungunya virus (CHIKV) was first detected in Brazil in 2014 with two lineages, North Asia and ECSA (East/Central/South Africa). The ECSA lineage dominated, causing significant outbreaks, especially in densely populated areas. The co-circulation of dengue and chikungunya has complicated diagnosis and treatment. The 2023 chikungunya epidemic in Minas Gerais, Southeast Brazil, prompted an assessment of associated mortality using WHO methodologies.The study used epidemiological data from the laboratory surveillance, disease notification and mortality systems of the Brazilian Ministry of Health. The North and Northeast Health Macroregions of Minas Gerais, with 2.5 million inhabitants, were analyzed. A Poisson regression model, excluding critical periods of COVID-19 and the chikungunya epidemic, estimated expected mortality. Excess deaths were calculated by comparing observed deaths with model estimates during the epidemic period.During the epidemic, there were 890 excess deaths attributed to chikungunya, translating into a mortality rate of 35.1/100,000 inhabitants. The excess mortality rate was significantly 60 times higher than the deaths reported by surveillance, with only 15 deaths confirmed. The correlation between excess deaths and laboratory-confirmed chikungunya cases was strong, while the correlation with dengue and COVID-19 was negligible. The results highlighted the serious underestimation of chikungunya mortality by epidemiological surveillance.We estimate that there were 890 excess deaths in the 2023 chikungunya epidemic in just one affected area of Minas Gerais, Brazil (2.5 million inhabitants). During the same year, only 420 chikungunya deaths were reported by all PAHO member countries. Epidemiological surveillance has underestimated the impact of this disease. Excess mortality is a crucial measure for understanding the impact of epidemics, as demonstrated by COVID-19 and influenza pandemics. The study highlights the need for complementary tools to traditional surveillance to better assess impacts on morbidity and mortality. Underreporting of chikungunya deaths has significant implications for public health responses and resource allocation. This study supports the importance of accurately quantifying mortality from emerging viruses to inform risk assessments and priority setting in public health interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.